These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 15467801)
1. [Use of psychopharmaceuticals--should serum concentration be checked?]. Andersen S; Refsum H; Tanum L Tidsskr Nor Laegeforen; 2004 Sep; 124(18):2362-4. PubMed ID: 15467801 [No Abstract] [Full Text] [Related]
2. [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group]. Baumann P; Hiemke C; Ulrich S; Eckermann G; Kuss HL; Laux G; Müller-Oerlingenhausen B; Rao ML; Riederer P; Zernig G; ; Rev Med Suisse; 2006 May; 2(67):1413-8, 1420-2, 1424-6. PubMed ID: 16786958 [TBL] [Abstract][Full Text] [Related]
3. [Psychopharmaceuticals and stomatological practice in psychiatric patients]. Swaczyna K; Konias V; Libus J Cesk Stomatol; 1979 Jan; 79(1):29-34. PubMed ID: 284849 [No Abstract] [Full Text] [Related]
4. Polypharmacy. Khanna R Aust N Z J Psychiatry; 1995 Dec; 29(4):691-2; author reply 692-3. PubMed ID: 8825836 [No Abstract] [Full Text] [Related]
5. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G; Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations]. Gerlach M; Rothenhöfer S; Mehler-Wex C; Fegert JM; Schulz E; Wewetzer C; Warnke A Z Kinder Jugendpsychiatr Psychother; 2006 Jan; 34(1):5-13. PubMed ID: 16485609 [TBL] [Abstract][Full Text] [Related]
7. [Psychopharmaceuticals monitoring in serum--do we know what we are doing?]. Gjerden P Tidsskr Nor Laegeforen; 2010 May; 130(9):924. PubMed ID: 20453949 [No Abstract] [Full Text] [Related]
8. [Drug monitoring and regulatory aspects of psychotropic drugs in childhood and adolescence]. Hebebrand J; Gerlach M Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):280-2. PubMed ID: 20306786 [No Abstract] [Full Text] [Related]
9. [Patient non-compliance in psychopharmacotherapy]. Kubacki A Psychiatr Pol; 1982; 16(4):297-306. PubMed ID: 7156244 [No Abstract] [Full Text] [Related]
10. Therapeutic drug monitoring. Principles and practice. Preskorn SH; Burke MJ; Fast GA Psychiatr Clin North Am; 1993 Sep; 16(3):611-45. PubMed ID: 8415237 [TBL] [Abstract][Full Text] [Related]
12. Monitoring plasma concentrations of psychotropic drugs as an aid to treatment. Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):445. PubMed ID: 538090 [No Abstract] [Full Text] [Related]
13. [Therapeutic drug monitoring in epileptology and psychiatry]. Brandt C; Baumann P; Eckermann G; Hiemke C; May TW; Rambeck B; Pohlmann-Eden B Nervenarzt; 2008 Feb; 79(2):167-74. PubMed ID: 17701390 [TBL] [Abstract][Full Text] [Related]
14. [The short cut of the psychiatry to psychopharmaceuticals can often be the longest way for the recovery of the patients]. Nyström H Lakartidningen; 1992 Mar; 89(10):761. PubMed ID: 1542240 [No Abstract] [Full Text] [Related]
15. Polypharmacy: when is it rational? Preskorn SH; Lacey RL J Psychiatr Pract; 2007 Mar; 13(2):97-105. PubMed ID: 17414685 [TBL] [Abstract][Full Text] [Related]
16. [Correlations between plasmatic concentrations and clinical effects of psychotropic drugs]. Predescu V; Costa D Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1979; 24(4):265-71. PubMed ID: 394259 [No Abstract] [Full Text] [Related]
17. Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidence. Ulrich S; Hiemke C; Laux G; Müller-Oerlinghausen B; Havemann-Reinecke U; Riederer P; Zernig G; Baumann P; Pharmacopsychiatry; 2007 May; 40(3):121-7. PubMed ID: 17541888 [TBL] [Abstract][Full Text] [Related]
18. The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs. Hendset M; Haslemo T; Rudberg I; Refsum H; Molden E Pharmacopsychiatry; 2006 Jul; 39(4):121-7. PubMed ID: 16871467 [TBL] [Abstract][Full Text] [Related]
19. [Mental disorders and their drug treatment in a patient with HIV infection]. Puuskari V; Leppävuori A; Raaska K; Kaivola T; Ristola M Duodecim; 2002; 118(5):449-56. PubMed ID: 12232981 [No Abstract] [Full Text] [Related]